Author/Authors :
Jalili, Mahdi Hematology-Oncology and Stem Cell Transplantation Research Center - Tehran University of Medical Sciences, Tehran, Iran , Salehzadeh-Yazdi, Ali Hematology-Oncology and Stem Cell Transplantation Research Center - Tehran University of Medical Sciences, Tehran, Iran , Mohammadi, Saeed Hematology-Oncology and Stem Cell Transplantation Research Center - Tehran University of Medical Sciences, Tehran, Iran , Yaghmaie, Marjan Hematology-Oncology and Stem Cell Transplantation Research Center - Tehran University of Medical Sciences, Tehran, Iran , Ghavamzadeh, Ardeshir Hematology-Oncology and Stem Cell Transplantation Research Center - Tehran University of Medical Sciences, Tehran, Iran , Alimoghaddam, Kamran Hematology-Oncology and Stem Cell Transplantation Research Center - Tehran University of Medical Sciences, Tehran, Iran
Abstract :
Background: Acute promyelocytic leukemia (APL) is a unique subtype of acute leukemia. APL is a curable disease; however, drug resistance, early mortality, disease relapse and treatment-related complications remain challenges in APL patient management. One issue underlying these challenges is that the molecular mechanisms of the disease are not sufficiently understood. Materials and Methods: In this study, we performed a meta-analysis of gene expression profiles derived from microarray experiments and explored the background of disease by functional and pathway analysis. Results: Our analysis revealed a gene signature with 406 genes that are up or down-regulated in APL. The pathway analysis determined that MAPK pathway and its involved elements such as JUN gene and AP-1 play important roles in APL pathogenesis along with insulin-like growth factor–binding protein-7. Conclusions: The results of this meta-analysis could be useful for developing more effective therapy strategies and new targets for diagnosis and drugs.
Keywords :
Functional analysis , Meta-Analysis , Gene expression profile , Acute promyelocytic leukemia